UK's FTSE 100 ticks lower as AstraZeneca drag offsets banks, mining gains

The UK's FTSE 100 index fell 0.2% to 10,472.5 points on Thursday, weighed down by AstraZeneca's disappointing trial results.

The UK's FTSE 100 ended slightly lower on Thursday as heavyweight AstraZeneca dropped after reporting disappointing ‌results from a late-stage trial, offsetting gains in mining and bank stocks.

The blue-chip FTSE 100 index fell 0.2% to 10,472.5 points, while the midcap FTSE 250 climbed 1% to snap a three-day losing ‌streak.